SLC22A2 and psychiatric disorder: However, we demonstrated a differential effect of SLC22A2 variants in participants with and without pre-existing psychiatric disorders; it was associated with a higher risk of DTG discontinuation (for any cause) in patients free of psychiatric comorbidities and with a lower rate of DTG interruption in the other group.